BiotechTube
Home/Magenta Therapeutics/Jason Gardner, D.Phil.
JG

Jason Gardner, D.Phil.

Co-founder, President & CEO

Magenta Therapeutics

Therapeutic Areas

Autoimmune DiseasesBlood CancersGenetic Diseases

Magenta Therapeutics Pipeline

DrugIndicationPhase
MGTA-117Conditioning for AML/MDS transplantPhase 1/2
MGTA-145 + plerixaforStem cell mobilizationPhase 2

Leadership Team at Magenta Therapeutics

MB
Michael Bell, Ph.D.
Co-founder, former CSO
MA
Michael A. Narachi
Former Chairman of the Board
View full Magenta Therapeutics profile